Medeor Therapeutics is Biotechnology in United States that focus on developer business. Founded in 2012. They cover business area such as developer, cellular immunotherapy, outcome, organ transplant recipient, approach, transplant immune tolerance, immuno-oncology, healthcare provider, transplant kidney function, graft rejection, currently available immunosuppression, anti-rejection) drug.
2012
( 12 years old in 2024 )
Developer
-
611 Gateway Boulevard
Suite 120
South San Francisco, CA 94080
United States
Private
developercellular immunotherapyoutcomeorgan transplant recipientapproachtransplant immune toleranceimmuno-oncologyhealthcare providertransplant kidney functiongraft rejectioncurrently available immunosuppressionanti-rejection) drug
* We use standard office opening hours in near Medeor Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Medeor Therapeutics is Biotechnology business from United States that founded in 2012 (12 years old in 2024), Medeor Therapeutics business is focusing on Developer.
Medeor Therapeutics headquarter office and corporate office address is located in 611 Gateway Boulevard Suite 120 South San Francisco, CA 94080 United States.
Medeor Therapeutics was founded in United States.
In 2024, Medeor Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Medeor Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
